Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
8.64
-0.26 (-2.92%)
Aug 14, 2025, 1:58 PM - Market open
Cyclacel Pharmaceuticals Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $5,040 → $2,640 | Strong Buy | Maintains | $5,040 → $2,640 | +30,455.56% | May 3, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 19, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $3,840 → $5,040 | Strong Buy | Maintains | $3,840 → $5,040 | +58,233.33% | Dec 19, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $28,800 | Buy | Maintains | $28,800 | +333,233.33% | May 25, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $36,000 → $28,800 | Buy | Maintains | $36,000 → $28,800 | +333,233.33% | Mar 7, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $61,200 | Buy | Initiates | $61,200 | +708,233.33% | Jul 18, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $61,200 | Buy | Initiates | $61,200 | +708,233.33% | Apr 30, 2021 |